Abstract
A scaffold-divergent approach to metronidazole-based compounds was described. Attempts to prepare N1-hydroxyethyl nitroimidazole-2-carboxylic acid resulted in rapid decarboxylation. A lactone (compound 8) serves as a stable and practical surrogate, enabling access to both oxadiazole and amide derivatives. Density functional theory calculations revealed that the instability of N1-hydroxyethyl nitroimidazole-2-carboxylic acid arises from a low-barrier decarboxylation pathway.
Funding Information
  • National Institute of General Medical Sciences (GM158092)

This publication has 36 references indexed in Scilit: